Search Results 551-560 of 16370 for Interindividual

1. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue - Mayo Clinic

   Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first- ...

2. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation - Mayo Clinic

   This study will evaluate the safety of intramuscular administration of PLX-R18 (allogenetic ex-vivo explanded placental adherent stromal cells) in subjects who ...

3. The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass - Mayo Clinic

   The hypothesis of this study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration in insulin secretion after Roux-en-Y Gastric ...

4. Belonging in Neuroscience - Employment and Academics - Mayo Clinic Research

   The Belonging in Neuroscience Committee seeks to increase belonging and inclusion in the Department of Neuroscience at Mayo Clinic.

5. A Study of Erlotinib as a Prevention in Trisomy 7 Positive Primary Sclerosing Cholangitis - Mayo Clinic

   Primary sclerosing cholangitis is a chronic inflammation of the bile ducts of unknown cause and eventually results in cirrhosis of the liver. These patients are ...

6. Brain and Cognition Effects of Cardio Resynchronization Therapy in Heart Failure - Mayo Clinic

   About this study. The purpose of this research study is to understand the effects of changes in the capability of the heart on brain function so that we can ...

7. LEAP 2 Chronic EFS - Mayo Clinic

   Prospective, single-arm, non-randomized, unblinded, chronic feasibility study designed to evaluate the safety and performance of the AVEIR™ Conduction System ...

8. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

   Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...

9. The Validation of the CAP-PRI (Chronic Acquired Polyneuropathy-Patient Reported Index) in Patients with Acquired and Idiopathic Polyneuropathy - Mayo Clinic

   The primary objective of this study is to validate the chronic acquired polyneuropathy-patient reported index (CAP-PRI) in subjects with acquired and idiopathic ...

10. A Study to Evaluate COVID Brain Advanced Imaging Network - Mayo Clinic

    The purpose of this study is to prospectively clarify the long-term consequences of SARS-CoV-2 infection in the CNS with multi-modal magnetic resonance (MR) ...